Earnings Feed
Sign Up
Home/Filings/4/0001144204-14-015084
4//SEC Filing

VENTRUS BIOSCIENCES INC 4

Accession 0001144204-14-015084

$ASMBCIK 0001426800operating
View on SEC.govCompany Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 3:25 PM ET

Size

15.4 KB

Accession

0001144204-14-015084

Insider Transaction Report

Form 4
Period: 2014-01-15
VENTRUS BIOSCIENCES INCVTUS
ELLISON RUSSELL H
DirectorChief Executive Officer
Transactions
  • Award

    Phantom Stock

    2013-04-05+50,000→ 50,000 total
    → Common Stock (50,000 underlying)
  • Award

    Stock Options (right to buy)

    2014-01-15+395,500→ 395,500 total
    Exercise: $3.81Exp: 2024-01-15→ Common Stock (395,500 underlying)
  • Award

    Restricted Stock Units

    2013-04-05+200,000→ 150,000 total
    Exp: 2016-06-30→ Common Stock (200,000 underlying)
Holdings

  • Stock Options (right to buy)

    Exercise: $6.00Exp: 2020-12-22→ Common Stock (573,599 underlying)
    573,599

  • Warrants (rights to buy)

    Exercise: $7.69Exp: 2014-11-08→ Common Stock (8,065 underlying)
    8,065

  • Common Stock

    15,000

  • Stock Options (right to buy)

    Exercise: $8.10Exp: 2022-01-15→ Common Stock (60,000 underlying)
    60,000
Footnotes (9)
  • [F1]One-third to vest on the first anniversary of the vesting commencement date (vesting commencement date is 1/15/2014); Remainder to vest in equal installments on the second and third anniversaries of the vesting commencement date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The restricted stock units vest in four equal amounts (25% each) as follows: 25% on the date of grant and 25% when the 20 trading day volume weighted average price of the Issuer's common stock equals or exceeds $4.15, $5.15 and $6.15. The unvested restricted stock units expire on June 30, 2016 if a vesting threshold has not been met by that date.
  • [F4]Upon the immediate vesting on April 5, 2013 of 50,000 restricted stock units granted to the reporting person on April 5, 2013, the reporting person elected to defer the receipt of those 50,000 shares of common stock, resulting in the accrual to his phantom stock account of 50,000 shares of phantom stock.
  • [F5]Each share of phantom stock represents the right to receive one share of the Issuer's common stock.
  • [F6]The phantom stock becomes payable on the earliest to occur of (a) termination of employment, (b) a change in control of the Issuer, or (c) April 1, 2015.
  • [F7]The options vested 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 1/15/2013.
  • [F8]The options vested 1/3 on 12/22/2010, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 12/22/2010.
  • [F9]The warrant vested in three installments on 3/21/08 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).

Documents

1 file

Issuer

VENTRUS BIOSCIENCES INC

CIK 0001426800

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001426800

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 3:25 PM ET
Size
15.4 KB
View on SEC.gov